PRESS RELEASE published on 08/12/2025 at 07:00, 8 months 21 days ago VALNEVA : Rapport Semestriel 2025
PRESS RELEASE published on 08/12/2025 at 07:00, 8 months 21 days ago Focus on sustainable profitability: Komax Group reduces costs considerably Komax Group achieves sustainable profitability by reducing costs considerably amid market challenges. Positive EBIT and cost savings of CHF 25 million confirmed in 2025 half-year results Market Challenges EBIT Cost Reduction Komax Group Sustainable Profitability
PRESS RELEASE published on 08/12/2025 at 07:00, 8 months 21 days ago Sonova expands Infinio range and enters new market segment with Phonak’s smallest and first rechargeable in-the-ear hearing aid Sonova expands Infinio range with Phonak's smallest rechargeable in-the-ear hearing aid, Phonak Virto R Infinio. The launch marks an important step in entering the market segment Sonova Hearing Aid Phonak Infinio Rechargeable
PRESS RELEASE published on 08/12/2025 at 07:00, 8 months 21 days ago LLB successfully concludes share repurchase programme Liechtensteinische Landesbank AG successfully concludes share repurchase programme holding 1.4% of share capital Share Repurchase Capital Structure Liechtensteinische Landesbank LLB Treasury Management
PRESS RELEASE published on 08/12/2025 at 07:00, 8 months 21 days ago SCHOTT Pharma delivers solid final third-quarter results SCHOTT Pharma reports solid Q3 2025 results with 1% revenue growth, 32.4% EBITDA margin, and strategic innovations Revenue Growth EBITDA Margin SCHOTT Pharma Innovations Q3 2025 Results
PRESS RELEASE published on 08/12/2025 at 07:00, 8 months 21 days ago Newron begins enrollment in pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS) Newron Pharmaceuticals initiates Phase III ENIGMA-TRS program with evenamide as add-on therapy for treatment-resistant schizophrenia patients, targeting TRS population Newron Pharmaceuticals Evenamide Phase III Treatment-resistant Schizophrenia ENIGMA-TRS Program
PRESS RELEASE published on 08/12/2025 at 07:00, 8 months 21 days ago Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates Valneva SE reports €97.6 million revenues in H1 2025, confirms 2025 financial outlook. Highlights financial results, R&D progress, and commercial updates Revenues Financial Results Valneva SE R&D Progress 2025 Outlook Commercial Updates
PRESS RELEASE published on 08/12/2025 at 07:00, 8 months 21 days ago Valneva publie ses résultats financiers du premier semestre 2025 et fait un point sur ses activités Valneva publie ses résultats financiers du premier semestre 2025 et fait un point sur ses activités. Chiffre d’affaires en hausse, trésorerie solide et perspectives confirmées. Détails disponibles sur le site de la société Résultats Financiers Perspectives Valneva Vaccins Premier Semestre 2025
PRESS RELEASE published on 08/12/2025 at 06:55, 8 months 21 days ago PolyPeptide delivers +24% growth in H1 2025, successful ramp-up at its Belgian site, 2025 full-year guidance revised towards the upper end of the range PolyPeptide Group reports +24% revenue growth in H1 2025, revises full-year guidance towards upper range. EBITDA improved to EUR 4.4 million, major investments in capacity expansion projects EBITDA Revenue Growth Capacity Expansion PolyPeptide Group Full-year Guidance
PRESS RELEASE published on 08/12/2025 at 06:55, 8 months 21 days ago TAG Immobilien AG reports strong growth in FFO I and EPRA NTA in the first half of 2025; positive valuation results in Germany and Poland; further decline in LTV TAG Immobilien AG reports strong growth in FFO I and EPRA NTA in the first half of 2025; positive valuation results in Germany and Poland; further decline in LTV TAG Immobilien AG EPRA NTA LTV FFO I Valuation Results
Published on 05/02/2026 at 01:30, 16 hours 50 minutes ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 17 hours 30 minutes ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 18 hours 20 minutes ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 18 hours 20 minutes ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/01/2026 at 22:30, 19 hours 50 minutes ago Nextech3D.ai Appoints New Independent Auditor
Published on 05/02/2026 at 15:35, 2 hours 44 minutes ago Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 22 hours 56 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 17:45, 1 day ago Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 04/30/2026 at 21:21, 1 day 20 hours ago CP -Mise à disposition du rapport financier annuel 2025
Published on 04/30/2026 at 20:00, 1 day 22 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 20:00, 1 day 22 hours ago AMA Corp PLC : Résultats 2025 & Chiffre d'affaires du 1er trimestre 2026
Published on 04/30/2026 at 19:16, 1 day 23 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:16, 1 day 23 hours ago AXA annonce les résultats de son Assemblée Générale